Regional differences in astrocyte activation in HIV-associated dementia

被引:0
|
作者
Vanzani, Maria C.
Iacono, Ruben F.
Caccuri, Roberto L.
Troncoso, Alcides R.
Berria, Maria I.
机构
[1] Univ Buenos Aires, Fac Med, Dept Microbiol, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, RA-1121 Buenos Aires, DF, Argentina
[3] Hosp Enfermedades Infecciosas Francisco J Muniz, Buenos Aires, DF, Argentina
关键词
AIDS; astrocyte; GFAP; immunocytochemistry; cytomorphometry;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since astrogliosis is a histological marker usually observed in HIV-associated dementia (HIV-D), we decided to investigate the potential relationship between the expression of glial fibrillary acidic protein (GFAP) and the regional distribution of cells positive (+) for this specific marker of astrocyte activation. Histological sections of brain tissues obtained at necropsy from 5 HIV-D patients and 5 age-matched controls without history of neuropsychiatric illness were immunostained with peroxidase. Mean numbers of GFAP(+) astrocytes were significantly increased in entorhinal cortex, hippocampus and subcortical white matter of patients, but values in frontal cortex and basal ganglia were similar to those of controls. In contrast, surface density of immunoreactive GFAP was significantly increased in all tested brain areas from all patients, including unusually affected regions such as entorhinal cortex and hippocampus. Therefore, such consistent finding of hypertrophic astrocytes, ranging from highest cell percentajes in subcortical white matter to lowest in basal ganglia indicates that quantification of surface density in GFAP (+) cells appears to be a more reliable approach to score gliosis than the counting of their cell nuclei. Because astrocyte activation involves both protective and detrimental effects on adjacent neuronal subsets, the evidence of regional differences in this reactive potential highlights the importance of accurately defining their contribution to the neuropathogenesis not only of HIV-D, but of a wide range of neuroclegenerative disorders.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 50 条
  • [31] Viral load in HIV-associated dementia - Reply
    Eilis, RJ
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 151 - 151
  • [32] HIV-associated chronic immune activation
    Paiardini, Mirko
    Mueller-Trutwin, Michaela
    IMMUNOLOGICAL REVIEWS, 2013, 254 : 78 - 101
  • [33] Neuron-astrocyte interaction in pathogenesis of HIV-associated pain
    Tang, S. J.
    Liu, X.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (02) : 363 - 363
  • [34] Kynurenic acid blunts A1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders
    Lun, Jingxian
    Li, Yubin
    Gao, Xuefeng
    Gong, Zelong
    Chen, Xiaoliang
    Zou, Jinhu
    Zhou, Chengxing
    Huang, Yuanyuan
    Zhou, Bingliang
    Huang, Pengwei
    Cao, Hong
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [35] Kynurenic acid blunts A1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders
    Jingxian Lun
    Yubin Li
    Xuefeng Gao
    Zelong Gong
    Xiaoliang Chen
    Jinhu Zou
    Chengxing Zhou
    Yuanyuan Huang
    Bingliang Zhou
    Pengwei Huang
    Hong Cao
    Journal of Neuroinflammation, 20
  • [36] Sex differences in HIV-associated cognitive impairment
    Sundermann, Erin E.
    Heaton, Robert K.
    Pasipanodya, Elizabeth
    Moore, Raeanne C.
    Paolillo, Emily W.
    Rubin, Leah H.
    Ellis, Ronald
    Moore, David J.
    AIDS, 2018, 32 (18) : 2719 - 2726
  • [37] Pathways to neuronal injury and apoptosis in HIV-associated dementia
    Marcus Kaul
    Gwenn A. Garden
    Stuart A. Lipton
    Nature, 2001, 410 : 988 - 994
  • [38] Identification of potential antibody markers in HIV-associated dementia
    Schutzer, SE
    Berger, JR
    Brunner, M
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 157 (1-2) : 120 - 125
  • [39] Validity of two scales in identifying HIV-associated dementia
    Berghuis, JP
    Uldall, KK
    Lalonde, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (02) : 134 - 140
  • [40] CLINICAL-NEUROPATHOLOGIC CORRELATION IN HIV-ASSOCIATED DEMENTIA
    GLASS, JD
    WESSELINGH, SL
    SELNES, OA
    MCARTHUR, JC
    NEUROLOGY, 1993, 43 (11) : 2230 - 2237